Slide 1: Making Lives Safer Through Nanotechnology
Making Lives Safer Through NANOTECHNOLOGY K E E P I N G S U R FA C E S C L E A N Corporate Presentation CSE: FNDX | OTCQB: FDXTF | FSE: E8D AUGUST 2024
Slide 2: Forward-Looking Statement
Forward-Looking Statement This presentation contains certain forward-looking statements within the meaning of Canadian securities legislation, including with respect to: the plans of the Company; expectations regarding industry trends, including with respect to the antimicrobial surface and coating
Slide 3: Developing Innovative Nanocoatings to Protect Surfaces from Lethal Pathogens
DEVELOPING INNOVATIVE NANOCOATINGS TO PROTECT SURFACES FROM LETHAL PATHOGENS REPEL bacteria, viruses and liquids REDUCE spread of bacteria & viruses CSE: FNDX | OTCQB: FDXTF | FSE:E8D AUGUST 2024 / 3
Slide 4: The Problem
The Problem Spread of pathogens is hard to control • Current disinfecting practices are not enough • One of the top 10 causes of death in the U.S.1,2 • ~98,000 deaths; costing ~$28 Bn annually in U.S. 2, 3 • Most bacteria are resistant to antibiotics making them difficult to treat Sources: 1. Future
Slide 5: Surfaces Are a Major Source of Pathogens
Surfaces Are a Major Source of Pathogens >80% of common infections are transmitted by touch SPORTS & HEALTHCARE OFFICES ENTERTAINMENT TRANSPORTATION SCHOOLS DOORKNOBS, PUSHDOORS HANDRAILS, ESCALATOR HANDLES PUSH PLATES ELEVATOR BUTTONS IV POLES, BED POLES CSE: FNDX | OTCQB: FDXTF | FSE:E8D AUGUST 20
Slide 6: Nanotechnology to Protect Surfaces
Nanotechnology* to Protect Surfaces Protected with Nano-Coating Provides immediate & continuous protection of surfaces reducing adhesion of bacteria and virus >98%1,2, 3 When a contaminated hand touches Unprotected a nano-coated protected surface, the contamination tends to stay on the hand and not
Slide 7: REPELWRAP Film
Adhesive backing to easily REPELWRAP™ Film apply to high touch surfaces Lead Product in Development to Protect High Touch Surfaces • Provides immediate & continuous protection • Target markets: healthcare and other high-touch, high traffic venues (i.e., transportation, schools) • >98% reduction in a
Slide 8: REPELWRAP Film – How It's Made
REPELWRAP™ Film – How It’s Made Inspired by Plasma the lotus leaf Treatment Nanoparticle Deposition Thermal Shrinking Deposition of nanoparticles Schematic diagram illustrating the manufacturing and thermal shrinking process of REPELWRAPTM film. CSE: FNDX | OTCQB: FDXTF | FSE:E8D AUGUST 2024 / 8
Slide 9: REPELWRAP Film: Path To Commercialization
REPELWRAP™ Film: Path To Commercialization Nanocoating Scale-up with Commercial Prototype Beta-Testing Formulation Dunmore* Production REPELWRAP™ Film Anticipate commercial production end of 2024 * Dunmore International Corp. (“Dunmore”), a Steel Partners Holdings L.P. (NYSE:SPLP) operating company
Slide 10: Spray Nano-Coating
Spray Nano-Coating To Provide Immediate and Continuous Protection of High Touch Surfaces • Expected to be easier to apply and expand applications Schematic illustration demonstrating how spray coating is applied. • 99.9% reduction in MRSA and Pseudomonas aeruginosa and 98% for Phi6 (a virus), due to
Slide 11: Antimicrobial & Antiviral Nano-Coating Market Offers Significant Opportunity
Antimicrobial & Antiviral Nano-Coating Market Offers Significant Opportunity SPORTS & ENTERTAINMENT Estimated global market revenue in 20261 OFFICES SCHOOLS ~$1.3 Bn Numerous Potential Industries ~ 10% CAGR (2026-2030) TRANSPORTATION HEALTHCARE Sources: 1. Future Markets Technology Report, Advanced
Slide 12: REPELWRAP Film and Spray Competitive Landscape
REPELWRAP™ Film and Spray Competitive Landscape Metal- REPELWRAP™ Film Liquid Containing** and & Spray* Disinfectants Photo-Activated Films Repels bacteria, viruses, +++ - - blood and liquids Instantly protects +++ +++ + 24-hour protection +++ - +++ Does not promote bacterial resistance +++ + + * Ba
Slide 13: Nano-Coated Catheters
Nano-Coated Catheters To Reduce Infections and Blood Clots • ~1 M foley catheter-associated infections & ~80 K Estimated TAM in 20331 central venous catheter-associated blood ~$13 Bn clots/infections at medical cost $0.3-$2.3 Bn 2,3 • >96% reduction in attachment of E. coli & >95% reduction in blood
Slide 14: Building A Robust Patent Portfolio
Building A Robust Patent Portfolio Methods of Making Omniphobic Materials with Hierarchical Structures and Uses Thereof Omniphobic Surfaces with Hierarchical Structures, and Methods of Making and Uses • US Patent Application Number # 18/683,578 Thereof • Canada Patent Application # CA3228893 • China
Slide 15: Capital Light Model
Capital Light Partner with contract manufacturers Model Secure licensing/distribution partners; revenue from royalties and milestones on net sales Maximize non-dilutive funding from grants CSE: FNDX | OTCQB: FDXTF | FSE:E8D AUGUST 2024 / 15
Slide 16: Growth Strategy
Growth Strategy • Explore additional uses of nanotechnology • Licensing/acquisition to expand product pipeline and intellectual property portfolio CSE: FNDX | OTCQB: FDXTF | FSE:E8D AUGUST 2024 / 16
Slide 17: Proven Management Team
Proven Management Team Dr. Carolyn Myers MBA, PhD Rose Zanic CPA, CA Tash Yousuf BSc President, CEO & Director CFO & Corporate Secretary Sr. Operations Manager • Principal of BioEnsemble LLC, assisting • Over 25 years of capital markets and • Expertise in project and operations start-ups and small p
Slide 18: Board of Directors and Advisors
Board of Directors and Advisors Stephen Randall CPA, CGA • Senior financial manager and Director with over 40 years’ experience. • Served in senior financial roles with both private, publicly traded and start-up companies in the manufacturing, Independent Board Member telecommunications, technology,
Slide 19: Featured in the Media
Featured in the Media SHARE Monday Management Update “The healthcare world needs innovative solutions like these to contribute to the global efforts to reduce the spread of potentially deadly microbes." openexchange.tv/monday-management-update-december-4th/fendx-technologies- cse-fndx?category=1297&
Slide 20: Key Highlights
Unique Disruptive Nanotechnology Award-winning, patent pending nanotechnology with instant repelling properties against microbes and liquids Global Need for Innovative Products to Keep Surfaces Clean Current practices are not sufficient, and infection rates continue to increase Accelerating Developm
Slide 21: Thank You!
Thank You! Reach out with any questions investor@fendxtech.com / fendxtech.com CSE: FNDX | OTCQB: FDXTF | FSE:E8D AUGUST 2024 / 21